Sign In
Buy RHHVF
$411.25
+0 (+0%)
At Close: Jun 22, 2026
U.S.-Iran deal will stick despite being a ‘bad, bad deal', says David Roche
12:15am, Friday, 19'th Jun 2026
Quantum Strategy's David Roche expects the US-Iran deal to hold, arguing both Washington and Tehran have strong incentives to keep Iranian oil flowing and avoid political disruption ahead of US midter
FDA Accepts Roche's Filing for Lunsumio VELO-Polivy in LBCL
01:50pm, Thursday, 18'th Jun 2026
FDA accepts RHHBY filing for Lunsumio VELO plus Polivy in relapsed or refractory LBCL as a potential chemotherapy-free treatment option.
FDA approves first generic version of Roche's flu drug
06:35pm, Wednesday, 17'th Jun 2026
The U.S. Food and Drug Administration approved the first generic version of Roche's Xofluza, a single-dose flu medicine for certain patients aged five years and older, the regulator said on Wedn
JAZZ's Zepzelca Fails to Meet Primary Goal in Lung Cancer Study
01:21pm, Monday, 15'th Jun 2026
Jazz Pharmaceuticals' Zepzelca fails a phase III lung cancer study, but strong first-line uptake and 2026 guidance remain unchanged.
Roche's Tecentriq Plus Chemo Gets FDA Priority Tag for Colon Cancer
10:47am, Thursday, 11'th Jun 2026
RHHBY wins FDA priority review for Tecentriq plus FOLFOX6 in stage III dMMR/MSI-H colon cancer, with a decision due in October 2026.
Nurix Therapeutics Deal With Roche Is Worth Betting On
09:48am, Thursday, 11'th Jun 2026
Recently, Nurix secured a partnership with Roche, which I believe has substantially derisked the stock as a whole. Similarly, this deal helps validate NRIX's bexobrutideg and its potential as a broade
Roche Vs. Pfizer: Obesity Week Presentations Deep Dive - What Investors Must Know
01:44pm, Wednesday, 10'th Jun 2026
Roche Holding AG and Pfizer Inc. are aggressively advancing obesity and T2D pipelines to capture share in the surging GLP-1 market. RHHBY's enicepatide shows strong Phase 2 weight loss data (22.7% at
Roche sticks to German investment after Eli Lilly cuts
03:39am, Tuesday, 09'th Jun 2026
The Swiss pharmaceutical and diagnostics giant Roche said it is sticking to its planned investments in Germany, unlike some of its competitors that have scaled back spending in the country.
Roche Holding AG (RHHBY) Shareholder/Analyst Call Transcript
06:48pm, Monday, 08'th Jun 2026
Roche Holding AG (RHHBY) Shareholder/Analyst Call Transcript
Roche Enters $2.3 Billion Blood-Cancer Drug Deal With Nurix Therapeutics
01:47am, Monday, 08'th Jun 2026
The Swiss drugmaker said it would pay Nurix $700 million upfront, while development costs would be split 60-40, with Roche taking the larger share.
Roche obesity drug helps patients shed 22.7% of weight in mid-stage trial
07:31pm, Friday, 05'th Jun 2026
Roche said on Friday that patients lost 22.7% of their body weight in a mid-stage trial of its dual-acting experimental obesity drug, with more than a quarter of those who received the highest dose
ASCO 2026: A quiet conference for European pharma, but AstraZeneca and Roche both have work to do
10:02am, Monday, 01'st Jun 2026
This year's American Society of Clinical Oncology (ASCO) conference has been a subdued affair for European pharmaceutical companies, with no major plenary presentations and little data capable of movi
Olema: The Market Overreacted To Roche's SERD Failure
09:55am, Friday, 15'th May 2026
Olema Pharmaceuticals is rated a cautious buy, with upside potential tied to pivotal OPERA-01 Phase 3 trial results expected in fall 2026. Palazestrant differentiates itself as a CERAN with superior m
Isomorphic Labs' $2.1 Billion Fundraise Is The Biggest Bet Yet On AI Drug Discovery
06:15pm, Wednesday, 13'th May 2026
On Tuesday, Isomorphic Labs, the Alphabet-founded firm that uses AI to accelerate drug development, said that it had raised $2.1 billion from investors led by Thrive Capital. That's a boatload of cash
Roche gets second European approval for Alzheimer's test
01:05am, Tuesday, 12'th May 2026
Swiss drugmaker Roche has received the CE mark - a European regulatory clearance allowing sale in the region - for its second Elecsys blood test for Alzheimer's disease, it said on Tuesday.
